Bio-Path Holdings, Inc. (BPTH)
0.0257
0.00 (0.00%)
USD |
OTCM |
Sep 09, 16:00
Bio-Path Holdings Debt to Equity Ratio : -0.0537 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0537 |
| March 31, 2026 | -0.0602 |
| December 31, 2025 | -0.0563 |
| September 30, 2025 | -0.0598 |
| June 30, 2025 | -0.0669 |
| March 31, 2025 | -0.1217 |
| December 31, 2024 | 0.539 |
| September 30, 2024 | -0.0365 |
| June 30, 2024 | 0.0426 |
| March 31, 2024 | -0.0324 |
| December 31, 2023 | 0.2562 |
| September 30, 2023 | 0.0558 |
| June 30, 2023 | 0.0333 |
| March 31, 2023 | 0.0214 |
| December 31, 2022 | 0.0156 |
| September 30, 2022 | 0.0152 |
| June 30, 2022 | 0.0138 |
| March 31, 2022 | 0.0133 |
| December 31, 2021 | 0.0092 |
| September 30, 2021 | 0.0089 |
| June 30, 2021 | 0.0095 |
| March 31, 2021 | 0.0098 |
| December 31, 2020 | 0.0219 |
| September 30, 2020 | 0.0267 |
| June 30, 2020 | 0.0233 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.022 |
| December 31, 2019 | 0.0197 |
| September 30, 2019 | 0.0269 |
| June 30, 2019 | 0.0227 |
| March 31, 2019 | 0.0056 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6845 |
| Anixa Biosciences, Inc. | 0.012 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.006M |
| Total Liabilities (Quarterly) | 9.693M |
| Shareholders Equity (Quarterly) | -9.687M |
| Current Ratio | 0.0006 |
| Net Debt Paydown Yield | -1.73% |